Glucosidase IIβ Polyclonal Antibody

    • Catalog No.:YT1919
    • Applications:WB;IF;ELISA
    • Reactivity:Human;Mouse
      • Target:
      • Glucosidase IIβ
      • Fields:
      • >>Protein processing in endoplasmic reticulum
      • Gene Name:
      • PRKCSH
      • Protein Name:
      • Glucosidase 2 subunit beta
      • Human Gene Id:
      • 5589
      • Human Swiss Prot No:
      • P14314
      • Mouse Swiss Prot No:
      • O08795
      • Immunogen:
      • The antiserum was produced against synthesized peptide derived from human GLU2B. AA range:81-130
      • Specificity:
      • Glucosidase IIβ Polyclonal Antibody detects endogenous levels of Glucosidase IIβ protein.
      • Formulation:
      • Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.
      • Source:
      • Polyclonal, Rabbit,IgG
      • Dilution:
      • WB 1:500 - 1:2000. IF 1:200 - 1:1000. ELISA: 1:10000. Not yet tested in other applications.
      • Purification:
      • The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
      • Concentration:
      • 1 mg/ml
      • Storage Stability:
      • -15°C to -25°C/1 year(Do not lower than -25°C)
      • Other Name:
      • PRKCSH;G19P1;Glucosidase 2 subunit beta;80K-H protein;Glucosidase II subunit beta;Protein kinase C substrate 60.1 kDa protein heavy chain;PKCSH
      • Observed Band(KD):
      • 59kD
      • Background:
      • This gene encodes the beta-subunit of glucosidase II, an N-linked glycan-processing enzyme in the endoplasmic reticulum. The encoded protein is an acidic phosphoprotein known to be a substrate for protein kinase C. Mutations in this gene have been associated with the autosomal dominant polycystic liver disease. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2014],
      • Function:
      • disease:Defects in PRKCSH are a cause of polycystic liver disease (PCLD) [MIM:174050]. PCLD is an autosomal dominant disorder and is characterized by the presence of multiple liver cysts of biliary epithelial origin. PCLD is a distinct clinical and genetic entity that can occur independently from autosomal dominant polycystic kidney disease (ADPKD) [MIM:173900], which in a considerable but uncertain proportion of cases is associated with hepatic cysts.,function:Regulatory subunit of glucosidase II.,pathway:Glycan metabolism; N-glycan metabolism.,similarity:Contains 1 PRKCSH domain.,similarity:Contains 2 EF-hand domains.,subunit:Heterodimer of a catalytic alpha subunit (GANAB) and a beta subunit (PRKCSH). Binds glycosylated PTPRC.,
      • Subcellular Location:
      • Endoplasmic reticulum .
      • Expression:
      • Lung,Lymphocyte,Platelet,
      • Products Images
      • Western Blot analysis of various cells using Glucosidase IIβ Polyclonal Antibody
      • Western Blot analysis of A549 cells using Glucosidase IIβ Polyclonal Antibody
      • Immunofluorescence analysis of HeLa cells, using GLU2B Antibody. The picture on the right is blocked with the synthesized peptide.
      • Western blot analysis of lysates from HepG2, 293, and HUVEC cells, using GLU2B Antibody. The lane on the right is blocked with the synthesized peptide.
      • Western blot analysis of the lysates from 293 cells using GLU2B antibody.